Herein, we designed engineered exosomes EmDEX@GA for locoregional PD‐1/PD‐L1 blockade and immune microenvironment remodeling in TDLNs to elicit systemic anti‐tumor immunity (Figure1). This evidence concerns the gene PDCD1 and neoplasm.